About TEDCO
TEDCO is a venture capital firm founded in 1998. It is primarily based out of Columbia, United States. As of Sep 2026, TEDCO is an active investor, having invested in 247 companies, with 5 new investments in the last 12 months. It primarily invests in Seed round in United States based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to Life Sciences and High Tech. Most recently it participated in the $***** Seed round of Syntes Overall, TEDCO portfolio has seen 3 IPOs and 29 acquisitions including key companies like Osmosis, Longeveron and Proscia. A lot of funds co-invest with TEDCO, with names like Maryland Momentum Fund sharing a substantial percentage of its portfolio. TEDCO has team of 53 people including 26 partners.Key Metrics
Team Members
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Seed, Grant (prize money) & 7 more
Portfolio IPOs
Deals in last 12 months
TEDCO's List of Top Investments
TEDCO has a portfolio of 247 companies. Their most notable investments are in NewConnect and The ClearMask.Their portfolio spans across United States, Israel, India and 3 more locations. They have invested in Enterprise Applications, Life Sciences, High Tech and 32 other sectors, across stages such as Seed, Grant (prize money) and 7 more. Here is the list of top investments by TEDCO:1. Osmosis
Educational resources platform for medical students and professionals. Allows students to upload curricular material, such as documents and lectures, create their own flashcards, questions, and answer these assessment items using spaced repetition. Scoreboard shows a student their accuracy, confidence, and retention of knowledge, while the platform recommends additional resources such as videos and articles.
Key facts about Osmosis
- Founded Year: 2012
- Location: Charlottesville (United States)
- Stage: Acquired
- Total Funding till date: $8.99M
- Employee Count: 336 as on Sep 30, 2026
- Investors: Felicis Ventures, Education Competition and 23 Others
- Latest Funding Round: Series A, Nov 07, 2023, $*****
- Highlight: Acquired

2. Mindoula
Behavioral health solutions for complex populations, payers, providers, and consumers. The company identifies, engages, and serves individuals facing complex behavioral health, medical, and social challenges across the care continuum. They offer solutions for payers, providers, and consumers, including care extension solutions and a full program suite. Their proprietary platform powers solutions for risk stratification, identification, assessment, outreach, enrollment, programmatic service, remote monitoring, analytics, and reporting. The company focuses on population health management, collaborative care, and addressing issues like substance-exposed pregnancies and sickle cell disease. They provide technology-driven solutions to improve outcomes, reduce costs, and enhance the quality of care. The company's systems and platforms have earned HITRUST Risk-based Certification, demonstrating a commitment to privacy, security, and compliance.
Key facts about Mindoula
- Founded Year: 2013
- Location: Bethesda (United States)
- Stage: Series B
- Total Funding till date: $31M
- Employee Count: 276 as on Sep 30, 2026
- Investors: TEDCO, AXA Venture Partners and 3 Others
- Latest Funding Round: Series B, Aug 06, 2020, $*****
- Highlight: Editors' Pick
3. Elsevier
Elsevier is a provider of information solutions to improve the performance of science, health, and technology professionals. The offered solutions include Scopus is the abstract and citation database of peer-reviewed literature: scientific journals, books and conference proceedings; ScienceDirect for researchers, teachers, students, healthcare, and information professionals to improve the way they search, discover, read, understand and share scholarly research; Mendeley is a free reference manager and academic social network that assist in research and collaboration with others; Evolve is a learning portal for healthcare educators and students to access online educational materials; Knovel helps engineers to solve complex problems by providing best practice insights, validated equations and materials and substances data.
Key facts about Elsevier
- Founded Year: 1880
- Location: Amsterdam (Netherlands)
- Stage: Early Stage
- Total Funding till date: $75K
- Employee Count: 13,183 as on Sep 30, 2026
- Investors: TEDCO, Silicon Alley Venture Partners and 5 Others
- Latest Funding Round: Grant (prize money), Dec 21, 2021, $*****
4. Longeveron
Developer of cellular therapies for aging-related and life-threatening conditions. The company's product include Lomecel-B is derived from culture-expanded medicinal signaling cells harvested from the bone marrow of adult human donors. It is used for the treatment of aging frailty, Alzheimer’s disease, metabolic syndrome, acute respiratory distress syndrome, and hypoplastic left heart syndrome.
Key facts about Longeveron
- Founded Year: 2014
- Location: Miami (United States)
- Stage: Public
- Total Funding till date: $1.05M
- Employee Count: 41 as on Sep 30, 2026
- Investors: Janus Henderson Investors, Logos and 6 Others
- Latest Funding Round: Post IPO, Mar 11, 2026, $*****
- Highlight: Public
5. Theradaptive
Developer of protein engineering technology creating targeted therapeutics for tissue repair. The company focuses on improving therapeutic delivery to enhance efficacy and reduce off-target side effects. It has developed material binding variants of recombinant proteins for clinical indications. These modified proteins enable safer and long-term delivery for vascular, soft tissue, and orthopedic repair.
Key facts about Theradaptive
- Founded Year: 2004
- Location: Boston (United States)
- Stage: Series B
- Total Funding till date: $50M
- Employee Count: 41 as on Sep 30, 2026
- Investors: TEDCO, Defense.gov and 4 Others
- Latest Funding Round: Series B, Jul 21, 2026, $*****
- Highlight: Editors' Pick
TEDCO's Year-on-Year Investment Trends
TEDCO has invested in 247 companies over the last 21 years, with an average of 11 new investments annually in the last 10 years. In 2025, it made 3 investments, while as of Sep 2026, it has made 5 investments in this year. Its most recent first time investment was in Syntes and most recent follow-on round was in Balance Theory.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 4 | 1 | 5 |
2025 | 3 | 0 | 3 |
2024 | 9 | 3 | 12 |
2023 | 22 | 6 | 28 |
2022 | 15 | 4 | 19 |
2021 | 10 | 2 | 12 |
2020 | 11 | 1 | 12 |
2019 | 4 | 2 | 6 |
2018 | 16 | 2 | 18 |
2017 | 13 | 4 | 17 |
TEDCO's Investments by Stage
TEDCO has made 138 investments in Seed stage with an average round size of $745K, 19 investments in Grant (prize money) stage with an average round size of $608K and 13 investments in Series A stage with an average round size of $5.15M.Stage of entry | No. of Investments |
|---|---|
Seed | 138 |
Grant (prize money) | 19 |
Series A | 13 |
Series B | 2 |
Angel | 1 |
Others | 4 |
Note: We have considered here, only first round of investments
TEDCO's Investments by Sector
TEDCO has a diverse portfolio, with companies operating in the Enterprise Applications, Life Sciences, HealthTech, High Tech and Enterprise Infrastructure. Notably, it has invested in 204 Tech companies, 178 Enterprise (B2B) companies, 105 Software companies and at least 55 companies focusing on Consumer (B2C).Sector | No. of Investments |
|---|---|
Enterprise Applications | 65 |
Life Sciences | 49 |
HealthTech | 28 |
High Tech | 27 |
Enterprise Infrastructure | 22 |
Others | 154 |
Note: We have considered here, only first round of investments
TEDCO's Investments by Geography
TEDCO has made most investments in United States (173), followed by Israel where it has made 2 investments.Country | No. of Investments |
|---|---|
United States | 173 |
Israel | 2 |
India | 1 |
Netherlands | 1 |
Nigeria | 1 |
Others | 1 |
Note: We have considered here, only first round of investments
TEDCO's recent investments
TEDCO has made 5 investments in 2026 so far. Syntes and Balance Theory are the latest among them.Here are the most recent investments by TEDCO:
Date | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Sep 17, 2026 | United States | Seed | 3177 | - | |
Jul 08, 2026 | United States | Series A | 7511 | [+1] | |
Apr 25, 2026 | United States | Seed | 8222 | - | |
Mar 31, 2026 | United States | Seed | 7281 | [+1] | |
Feb 11, 2026 | United States | Series A | 6444 | - |
IPOs and Publicly Listed companies in TEDCO's Portfolio
3 of TEDCO's portfolio companies have become public. BullFrog AI got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Feb 2023 at marketcap of $36.7M and Longeveron got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ) at marketcap of $187M.Here are TEDCO's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Feb 14, 2023 | Apr 07, 2020 | Seed | 3346 | |
Feb 12, 2021 | Nov 06, 2018 | Grant (prize money) | 5587 | |
- | Mar 23, 2016 | Seed | 6190 |
Acquired companies in TEDCO's Portfolio
29 companies from TEDCO's portfolio have been acquired. The most recent acquisition was Proscia in Oct 2026 by Agilent for $*****.Here are TEDCO's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Oct 13, 2026 | Dec 14, 2016 | Seed | 7036 | |
Mar 31, 2026 | Sep 13, 2012 | Seed | 6586 | |
Jan 09, 2025 | Mar 04, 2015 | Seed | 6295 | |
Mar 26, 2024 | Feb 02, 2023 | Seed | 6661 | |
Mar 06, 2024 | Feb 02, 2018 | Seed | 4693 |
Team profile of TEDCO
TEDCO has a team of 53 members including 26 Partners and 4 Principals located in United States. TEDCO's team does not sit on the board of any company as of now.Here is a list of top team members in TEDCO:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Columbia | - | - | |
Partner | Potomac | - | - | |
Partner | Montgomery Village | - | ||
Partner | Washington | - | ||
Partner | Chester | - | - | |
Partner | Waldorf | - | - | |
Partner | Baltimore | - | - | |
Partner | Ellicott City | - | - |
Co-investors of TEDCO
Over the past 21 years, 379 investors have co-invested in TEDCO's portfolio companies. This includes funds and angels.
- Invested before TEDCO: HHS, National Science Foundation and 87 others have invested in rounds before TEDCO. There are 14 companies where HHS has invested before TEDCO and 6 companies where National Science Foundation has invested before TEDCO.
- Top Co-investors of TEDCO: 82 investors entered a company along with TEDCO. These include investors like Maryland Momentum Fund (4 companies).
- Invested after TEDCO: A total of 208 investors have invested in TEDCO's portfolio after their investments. Top Investors include Abell Foundation (8 companies), National Science Foundation (7 companies) and NIH (7 companies).
Recent News related to TEDCO
•
Maryland Stem Cell Research Commission Awards Over $4.8 Million in First FY2027 Funding CyclePR Newswire•Sep 29, 2026•Maryland Stem Cell Research Fund, TEDCO
•
RELAI Launches Verifiable Continual Learning Platform for AI Agents, Backed by $6.9MAccess Newswire•Jun 10, 2026•RELAI, Non sibi ventures, TEDCO, .406 Ventures
•
TEDCO, USM and WTCI Collaborate with the Kingdom of Jordan for Informative WebinarPR Newswire•Mar 11, 2026•TEDCO
•
TEDCO Invests in KnowledgeNet.ai to Bridge the Sales Execution Gap with AI-Powered Outbound IntelligenceSalesTech Star•Feb 11, 2026•KnowledgeNet.ai, TEDCO
•
•
•
TEDCO Announces Agreement with Kunicorn Investment LLC to Expand Innovation EcosystemBenzinga•Nov 07, 2025•TEDCO, https://koreaunicorn.com
•
TEDCO Announces Agreement for $50M Investment with TAIIDA and SFIC GroupPR Newswire•Nov 06, 2025•Sficwealth, TEDCO, TAIIDA
•
Maryland Stem Cell Research Fund Awards $4.7 million to Support Innovations in Stem Cell ResearchPR Newswire•Oct 02, 2025•Stemina Biomarker Discovery, RoosterBio, ReproCELL, Theradaptive and 3 others
•
TEDCO Selects Collide Capital to Manage and Invest Allocated SSBCI FundingPR Newswire•Jul 17, 2025•Collide, TEDCO